Tenofovir comedication does not impair the steady-state pharmacokinetics of ritonavir-boosted atazanavir in HIV-1-infected adults

Author： Hentig Nils Dauer Brenda Haberl Annette Klauke Stefan Lutz Thomas Staszewski Schlomo Harder Sebastian

Publisher： Springer Publishing Company

ISSN： 0031-6970

Source： European Journal of Clinical Pharmacology, Vol.63, Iss.10, 2007-10, pp. : 935-940

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

Influence of tenofovir, nevirapine and efavirenz on ritonavir-boosted atazanavir pharmacokinetics in HIV-infected patients

By Dailly Eric Tribut Olivier Tattevin Pierre Arvieux Cédric Perré Philippe Raffi François Jolliet Pascale

European Journal of Clinical Pharmacology, Vol. 62, Iss. 7, 2006-07 ,pp. : 523-526

Springer Publishing Company

Access to resources Recommend Favorite

Ritonavir-boosted darunavir: a powerful option for treatment-experienced HIV-1-infected patients

By Menééndez-Arias Luis Matamoros Tania ÁÁlvarez Mar

Future Virology, Vol. 3, Iss. 5, 2008-09 ,pp. : 423-434

Future Medicine

Access to resources Recommend Favorite

Atazanavir/ritonavir-based combination antiretroviral therapy for treatment of HIV-1 infection in adults

By Achenbach Chad J Darin Kristin M Murphy Robert L Katlama Christine

Future Virology, Vol. 6, Iss. 2, 2011-02 ,pp. : 157-177

Future Medicine

Access to resources Recommend Favorite

Atazanavir/ritonavir/tenofovir: Urinary calculi: case report

Reactions Weekly, Vol. 1, Iss. 1203, 2008-01 ,pp. : 11-12

Adis International

Access to resources Recommend Favorite

Effect of Food on the Steady-State Pharmacokinetics of Delavirdine in Patients with HIV Infection

By Morse G.D.

Clinical Drug Investigation, Vol. 23, Iss. 4, 2003-01 ,pp. : 255-261

Adis International

Access to resources Recommend Favorite